Professor Roland Stocker originally trained as a biochemist at the ETH Zürich (Switzerland), and completed his PhD at the Australian National University in Canberra, Australia. He has held appointments at the University of California (Berkeley, USA) and the University of Berne (Switzerland), and has led research teams at the Centre for Vascular Research at the University of NSW, The University of Sydney, and the Victor Chang Cardiac Research Institute, as well as a previous team at the Heart Research Institute.
Prof Stocker has been an NHMRC Research Fellow since 1994, and a Senior Principal Research Fellow since 2001. He has received numerous awards, including the inaugural Simon Wolff Contrarian Award for work on vitamin E, the Paul Nestel Lecturer of the Australian Atherosclerosis Society and the Lifetime Achievement Award from the Society of Free Radical Research (Australasia). He is a member of the Australian Academy of Health and Medical Sciences, and the Swiss Academy of Medical Sciences.
Prof Stocker is recognised internationally as an expert in redox biology, in particular for his research on antioxidants, and mechanisms and prevention of atherosclerotic vascular disease. His key scientific contributions include his work on bilirubin as an antioxidant, which contributed to a change in the threshold at which hyperbilirubinemia is treated in clinics. Another key contribution is his work on vitamin E, which led to a change in how parenteral nutrition is handled in NICUs in Australia and New Zealand, and provides a scientific rationale for why vitamin E supplements do not positively impact cardiovascular disease outcome.